相关实验视频

Updated: Jun 12, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

强化脑瘤管理:仿真抗原受体巨细胞治疗

Fan Feng¹, Jianyu Shen¹, Qichao Qi¹

¹Department of Neurosurgery, Qilu Hospital and Institute of Brain and Brain-Inspired Science, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong, China.

|September 23, 2024

概括

化学抗原受体 (CAR) 巨细胞提供了针对脑瘤的新型免疫疗法,通过重聚瘤相关巨细胞来对抗癌症. 这种方法增强了抗瘤免疫力,并招募T细胞用于改进治疗策略.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
神经瘤学神经瘤学

背景情况:

由于复杂的生物学和有限的治疗选择,脑瘤存在重大治疗挑战.
免疫疗法,特别是化学抗原受体 (CAR) 技术,正在成为一个有前途的战略.
瘤相关巨细胞 (TAMs) 通常在免疫抑制性脑瘤微环境中促进瘤生长.

研究的目的:

审查CAR-巨细胞 (CAR-M) 作为治疗脑瘤的新型免疫疗法的潜力.
探索CAR-M疗法如何克服TAMs带来的挑战.
讨论优化CAR-M疗法的策略及其在神经瘤学中的未来方向.

主要方法:

审查关于CAR技术,巨细胞和脑瘤免疫学的现有文献.
对CAR-M发挥抗瘤作用的机制的分析.
在脑瘤中探索CAR-M治疗的挑战和优化策略.

主要成果:

汽车巨细胞可以有效地将M2型TAM复极化为M1型表型,表现出强大的抗瘤活性.
卡尔-M疗法有可能将T细胞招募到瘤部位,重塑免疫微环境.
这种方法提供了一种有希望的策略,可以抑制脑瘤的生长并改善治疗结果.

结论:

汽车巨细胞疗法代表了脑瘤免疫疗法的重大进步.
重振TAM和招募T细胞是CAR-M疗效的关键机制.
进一步的研究和优化对于实现CAR-M在治疗中枢神经系统恶性瘤方面的全部潜力至关重要.

关键词:

大脑瘤是什么?化学抗原受体的化学抗原受体免疫治疗是一种免疫疗法.巨细胞是一个巨细胞.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.